BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 23780967)

  • 21. A Fas agonist induces high levels of apoptosis in haematological malignancies.
    Greaney P; Nahimana A; Lagopoulos L; Etter AL; Aubry D; Attinger A; Beltraminelli N; Huni B; Bassi I; Sordat B; Demotz S; Dupuis M; Duchosal MA
    Leuk Res; 2006 Apr; 30(4):415-26. PubMed ID: 16181674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Susceptibility genes for the development of autoimmune thyroid disease].
    Shirasawa S
    Nihon Rinsho; 2006 Dec; 64(12):2208-14. PubMed ID: 17154080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local bone marrow renin-angiotensin system in primitive, definitive and neoplastic haematopoiesis.
    Haznedaroglu IC; Beyazit Y
    Clin Sci (Lond); 2013 Mar; 124(5):307-23. PubMed ID: 23157407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toll-like receptors: key activators of leucocytes and regulator of haematopoiesis.
    McGettrick AF; O'Neill LA
    Br J Haematol; 2007 Oct; 139(2):185-93. PubMed ID: 17897294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiogenesis in hematologic malignancies.
    Moehler TM; Neben K; Ho AD; Goldschmidt H
    Ann Hematol; 2001 Dec; 80(12):695-705. PubMed ID: 11797109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic connections between autoimmune disorders and haematological malignancies.
    Javierre BM; Esteller M; Ballestar E
    Trends Immunol; 2008 Dec; 29(12):616-23. PubMed ID: 18951845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Roles of microRNAs in hematopoietic cell differentiation and the related tumors].
    Yang GH; Wang F; Zhang JW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Jun; 29(3):425-9. PubMed ID: 17633476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased bone marrow microvascular density in haematological malignancies is associated with differential regulation of angiogenic factors.
    Negaard HF; Iversen N; Bowitz-Lothe IM; Sandset PM; Steinsvik B; Ostenstad B; Iversen PO
    Leukemia; 2009 Jan; 23(1):162-9. PubMed ID: 18800145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcription factor GATA-3 is required for development of the T-cell lineage.
    Ting CN; Olson MC; Barton KP; Leiden JM
    Nature; 1996 Dec; 384(6608):474-8. PubMed ID: 8945476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of the Wilms tumour gene (WT1) in normal and malignant haematopoiesis.
    Ariyaratana S; Loeb DM
    Expert Rev Mol Med; 2007 May; 9(14):1-17. PubMed ID: 17524167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of CD154 in haematopoietic development.
    Seijkens T; Engel D; Tjwa M; Lutgens E
    Thromb Haemost; 2010 Oct; 104(4):693-701. PubMed ID: 20694278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiangiogenesis in haematological malignancies.
    Li WW; Hutnik M; Gehr G
    Br J Haematol; 2008 Dec; 143(5):622-31. PubMed ID: 19036013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Angiogenesis and endothelial cells in blood neoplasms].
    Usnarska-Zubkiewicz L; Poreba M; Kuliczkowski K
    Przegl Lek; 2006; 63(3):146-50. PubMed ID: 16969900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue factor as an effector of angiogenesis and tumor progression in hematological malignancies.
    López-Pedrera C; Barbarroja N; Dorado G; Siendones E; Velasco F
    Leukemia; 2006 Aug; 20(8):1331-40. PubMed ID: 16728982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiogenesis in hematologic malignancies.
    Mesters RM
    Ann Hematol; 2002; 81 Suppl 2():S72-4. PubMed ID: 12611085
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of transcriptional activities of AP-1 and c-Jun by a new zinc finger protein ZNF394.
    Huang C; Wang Y; Li D; Li Y; Luo J; Yuan W; Ou Y; Zhu C; Zhang Y; Wang Z; Liu M; Wu X
    Biochem Biophys Res Commun; 2004 Aug; 320(4):1298-305. PubMed ID: 15249231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of the GATA2 transcription factor in normal and malignant hematopoiesis.
    Vicente C; Conchillo A; García-Sánchez MA; Odero MD
    Crit Rev Oncol Hematol; 2012 Apr; 82(1):1-17. PubMed ID: 21605981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcription factor interplay during Drosophila haematopoiesis.
    Waltzer L; Gobert V; Osman D; Haenlin M
    Int J Dev Biol; 2010; 54(6-7):1107-15. PubMed ID: 20711988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assembly of the oncogenic DNA-binding complex LMO2-Ldb1-TAL1-E12.
    Ryan DP; Duncan JL; Lee C; Kuchel PW; Matthews JM
    Proteins; 2008 Mar; 70(4):1461-74. PubMed ID: 17910069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant expression of beta-catenin discriminates acute myeloid leukaemia from acute lymphoblastic leukaemia.
    Serinsöz E; Neusch M; Büsche G; Wasielewski R; Kreipe H; Bock O
    Br J Haematol; 2004 Aug; 126(3):313-9. PubMed ID: 15257703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.